Improper Medicare payments down $20.7B since 2014, CMS data show
Fierce Healthcare
NOVEMBER 16, 2021
since 2014, CMS data show. Improper Medicare payments down $20.7B Tue, 11/16/2021 - 07:15.
2014 Related Topics 
Medicaid coverage for substance abuse treatment improved substantially since 2014: study
Fierce Healthcare
AUGUST 11, 2023
Access to care for Medicaid fee-for-service beneficiaries with substance use disorder has improved from 2014 until 2021, but much more can be done to improve it further, researchers say. There have been substantial improvements in coverage for substance use disorder and opioid use disorder since 2014, according to a study in JAMA Network.
98 Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
HPV Vaccination Rates Could Improve With Increased Reimbursement
Drug Topics
JULY 28, 2023
of women aged 18-59 in 2013-2014. According to the CDC, HPV is the most commonly sexually transmitted infection in the US, with a prevalence of 45.2% of men and 39.9%
Vaccines 247
247 Vaccines 247
247 
What the 2014 Ebola outbreak taught this biotech CEO about persuasion
PharmaVoice
JULY 18, 2023
A former WHO epidemiologist is applying lessons learned during the Ebola epidemic to her work leading a company at the forefront of women’s health: the reproductive microbiome.
130 
FDA Approves Pembrolizumab Plus Chemoradiotherapy to Treat FIGO 2014 Stage III-IVA Cervical Cancer
Pharmacy Times
JANUARY 15, 2024
The approval was based on the results of a phase 3 trial that found an improvement in progression-free survival among individuals treated with pembrolizumab.
FDA 123
123 FDA 123
123 
Fierce Healthcare - Untitled Article
Fierce Healthcare
MARCH 12, 2025
A recent analysis, which looked at ophthalmology practice acquisitions between 2014 and 2021, outlines movement among the clinical workforce and changes in its characteristics that stem from private equity's increasing role in care.
120 
FDA Approves Self-Collection cobas HPV Test for Early Detection of Cervical Cancer Early
Pharmacy Times
MAY 20, 2024
In 2014, the cobas human papillomavirus test was approved by the FDA for first-line, primary screening in women aged 25 years and older.
FDA 132
132 FDA 132
132 
FDA Approves IgG-Hyaluronidase Recombinant for the Treatment of Adult Patients With CIDP
Pharmacy Times
JANUARY 16, 2024
Previously, IgG-hyaluronidase recombinant was approved by the FDA in 2014 for the treatment of primary immunodeficiency in adult patients and has expanded to include some pediatric patients.
FDA 145
145 FDA 145
145 
Five Things Pharmacists Should Know About Ventilator Associated Pneumonia (VAP)
IDStewardship
DECEMBER 1, 2022
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update. Infect Contr Hosp Epidemiol 2014; 35(8): 915–36. Clin Infect Dis 2016; 63 (5):e61–e111. . Klompas, M., Branson, R., Eichenwald, E. Tamma, Samuel L. Aitken, Robert A. Bonomo, et al.
Hospitals 348
348 Hospitals 348
348 
Nonpharmacologic Treatments Surpass Opioid Treatment for Patients with Chronic, Nonsurgical Pain
Pharmacy Times
NOVEMBER 11, 2022
Updated prescribing guidelines issued in 2014 and 2016 may explain lower use of opioids by 11.7% among patients with chronic, nonsurgical pain.
123 
Direct-acting Antivirals for Hepatitis C Infection Are Underused in the US, Study Finds
Pharmacy Times
DECEMBER 15, 2022
While the use of direct-acting antiviral treatment for hepatitis C virus increased from 2014 to 2018, treatment rates have declined since 2019 and remain suboptimal.
123 
AstraZeneca hit CEO Pascal Soriot's $45B revenue goal after all. But is Enhertu approaching a plateau?
Fierce Pharma
FEBRUARY 8, 2024
billion in 2023 revenues, AstraZeneca has met the $45 billion-by-2023 goal CEO Pascal Soriot established in 2014 when he was fending off a takeover bid from Pfizer. AstraZeneca has met the $45 billion-by-2023 revenue goal that CEO Pascal Soriot established in 2014.
103 
Generics expected to improve access for patients with idiopathic pulmonary fibrosis
Pharmaceutical Technology
SEPTEMBER 27, 2023
The idiopathic pulmonary fibrosis (IPF) market is underserved with just two licensed pharmaceutical treatments approved by the FDA in 2014.
FDA 105
105 FDA 105
105 
Keytruda Granted Latest FDA Approval in Cervical Cancer
Pharmaceutical Commerce
JANUARY 15, 2024
FDA approves Keytruda (pembrolizumab) combined with chemoradiation for the treatment of patients with FIGO 2014 stage III to IVA cervical cancer, which is the 39th overall approved indication for the drug in the United States.
FDA 107
107 FDA 107
107 
Why doesn’t the U.S. have more Black midwives?
STAT
SEPTEMBER 18, 2023
Universities have also expanded their course offerings, with the number of new students enrolled in accredited midwifery programs growing from 1,006 students in 2014 to 1,214 in 2018 , according to the latest data available. more than doubled from 1991 and 2012 and has continued to grow steadily in the years since. Read the rest…
Hospitals 145
145 Hospitals 145
145 
STAT+: New NIH head says government has fallen behind pharma on clinical trials
STAT
NOVEMBER 14, 2023
Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period. ” A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Continue to STAT+ to read the full story…
143 
STAT+: A novel spinal cord stimulator treats paralysis without surgery. FDA will rule on it soon
STAT
MAY 20, 2024
After his spinal cord injury in 2014, Sherown Campbell worked hard to regain as much bodily function as he could. Once a dedicated athlete, Campbell had to learn the new limits of his body. One of them, jarringly, was his body’s inability to sweat.
FDA 123
123 FDA 123
123 
Novo Nordisk weight-management drug lands FDA approval
Outsourcing Pharma
JUNE 7, 2021
The pharmacy company's Wegovy (semaglutide) is the first therapy designated for chronic weight management that the agency has granted approval since 2014.
FDA 98
98 FDA 98
98 
The Issue with Reissue: PTE Edition
The FDA Law Blog
MARCH 18, 2025
In the generic filers view, the regulatory review period should have started in January 2014 when the patent was reissued rather than in April 2004, when the IND was opened, because the reissued patent did not exist in April 2004. The plain text of 35 U.S.C.
STAT+: Oncologists more likely to provide low-value care after receiving pharma money, study finds
STAT
OCTOBER 25, 2023
The researchers examined Medicare beneficiaries who were diagnosed with cancer and received treatment from 2014 through 2019. Overall, the proportion of patients who were prescribed so-called low-value drugs was higher when their oncologist accepted industry payments, according to the study, published in the BMJ.
Chemotherapy 140
140 
STAT+: For Parkinson’s disease, advances spurred by Apple Watch offer a glimmer of hope
STAT
OCTOBER 24, 2023
Since the Apple Watch was unveiled in 2014, it has been trumpeted not only as a high tech fashion accessory, but also as a way for people to track their own health and fitness. It has evolved as a popular cardio tool for such uses as heart rate monitoring, recording your ECG, and measuring the oxygen saturation of your blood.
STAT+: A Q&A with the CEO of CRISPR Therapeutics on a historic approval and the road ahead
STAT
DECEMBER 8, 2023
Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics were all started in the 2013-2014 time frame with the same goal of turning the nascent CRISPR gene-editing technology into medicines.
124 
STAT+: New antibiotics were underprescribed for hard-to-treat infections, study finds
STAT
APRIL 19, 2024
hospitals and then tracked usage of seven antibiotics that were approved by the Food and Drug Administration between 2014 and 2019. They examined data spanning January 2016 through June 2021 at 619 U.S. Continue to STAT+ to read the full story…
Hospitals 128
128 Hospitals 128
128 
Takeda picks up 2nd FDA-approved indication for immune globulin treatment HyQvia
Fierce Pharma
JANUARY 16, 2024
It is the second indication for HyQvia, which was first endorsed in 2014. The FDA has approved Takeda's HyQvia as a maintenance therapy for CIDP.
Immunization 93
93 
STAT+: GSK is replacing its popular Flovent inhaler with authorized generics, raising cost concerns for asthma patients
STAT
JANUARY 5, 2024
The timing of the change is telling: Flovent’s price rose nearly 50% since 2014, according to GoodRx , leaving the drug vulnerable to the new Medicaid penalties going into effect as of this year for medications with price increases that outpace inflation. Prasco, a U.S.
Labelling 123
123 Labelling 123
123 
Opinion: Inclusive immigration policies protect America’s health care
STAT
DECEMBER 13, 2024
When I left Syria in 2014, I had a dream of becoming a U.S.-trained trained physician. I quickly realized that the American dream is real and that hard work truly pays off.
100 
STAT+: Study finds heavier reliance on nurse practitioners, physician assistants after private equity takeovers
STAT
JANUARY 9, 2023
The researchers used clinician-level and practice acquisition data to study changes in the makeup of clinician workforces at private equity-acquired versus non-private equity-acquired dermatology, ophthalmology, and gastroenterology practices between 2014 and 2019.
Hospitals 100
100 
STAT+: Solicitor general recommends Supreme Court shouldn’t review an Amgen patent case
STAT
SEPTEMBER 24, 2022
Amgen filed a lawsuit against the other companies in 2014 for allegedly infringing patents when they sought regulatory approval for their own medication. Continue to STAT+ to read the full story…
96 
Takeda ponies up €130M to settle tax linked to distant AbbVie-Shire breakup fee
Fierce Pharma
OCTOBER 18, 2023
Back in 2018, Irish authorities hit Shire with a €398 million charge tied to that company’s rejection of AbbVie’s takeover bid in 2014. . | Takeda will pay €130 million (about $137 million) to resolve a tax assessment from the Irish Revenue Commissioners, the company said Wednesday. Takeda ultimately purchased Shire for $62 billion in 2019.
87 
Five Lessons Learned About Antimicrobial Stewardship Metrics
IDStewardship
DECEMBER 13, 2024
Expert Consensus on Metrics to Assess the Impact of Patient-Level Antimicrobial Stewardship Interventions in Acute-Care Settings. Antimicrobial Stewardship Programs: Appropriate Measures and Metrics to Study their Impact. Outcomes and Metrics for Antimicrobial Stewardship: Survey of Physicians and Pharmacists.
Communication 225
225 
STAT+: Spain’s antitrust regulator fines drugmaker for ‘excessive’ pricing of a rare disease drug
STAT
NOVEMBER 15, 2022
But the drug was bought by Leadiant Biosciences which, by 2014, began raising the price in several countries before withdrawing the medicine from the market entirely the following year. At issue is a medicine called CDCA that is used to treat people with a rare genetic metabolic disease known as cerebrotendinous xanthomatosis, or CTX.
96 
AstraZeneca uses Farxiga's versatility to guide pipeline work, exec says
Fierce Pharma
AUGUST 28, 2023
With seven posters and nine presentations on Farxiga over the weekend at the European Society of Cardiology (ESC) scientific sessions in Amsterdam, AstraZeneca made it clear that it has lots to say | As AstraZeneca's Farxiga has added four indications over the last five years—on top of its initial 2014 approval for Type 2 diabetes—its spillover (..)
92 
How doulas could help prevent the harms that can happen during childbirth
STAT
NOVEMBER 4, 2022
When Tamiya Griffin was expecting her first child in 2014, she had what she thought was a straightforward plan: deliver at the hospital down the road, the same place her mother gave birth to her. But when Griffin, then a 22-year-old senior in college, went into labor a few weeks early, she had to undergo an emergency C-section.
Hospitals 104
104 Hospitals 104
104 
STAT+: Diagnosed with cancer, a pharmaceutical executive became a patient advocate and changed drug development. It took decades
STAT
SEPTEMBER 3, 2024
“That she took everything she knew about the pharmaceutical industry, having been part of it, and has really built a powerful advocacy for multiple myeloma patients, is remarkable,” said Tony Coles, who was CEO of Onyx Pharmaceuticals, a myeloma-focused biotech, from 2008 to 2014.
Insurance 142
142 Insurance 142
142 
STAT+: FDA approves high blood pressure device from Recor Medical
STAT
NOVEMBER 8, 2023
But a large-scale clinical trial from Medtronic in 2014 called renal denervation’s efficacy into question, as it did not significantly reduce blood pressure compared to placebo treatments. The therapy, a simple procedure to reduce the blood pressure of millions of Americans , was once seen as a boon for cardiologists and device makers.
FDA 106
106 FDA 106
106 
STAT+: U.S. Supreme Court gives Amgen a boost by agreeing to review a closely watched patent case
STAT
NOVEMBER 4, 2022
Amgen filed a lawsuit against the other companies in 2014 for allegedly infringing patents when they sought regulatory approval for their own medication. At issue is a long-running battle between Amgen and a pair of rivals — Sanofi and Regeneron Pharmaceuticals — over the market for injectable cholesterol treatments.
91 
Does DIY still have a place in diabetes care?
STAT
JUNE 24, 2023
When Dana Lewis built her first artificial pancreas in 2014, she — and millions of other people with type 1 diabetes — didn’t have another option.
FDA 97
97 FDA 97
97 
STAT+: Former FDA official lays out how to keep patients safe from risky medical devices
STAT
OCTOBER 2, 2023
Dispirited, she left in 2014 to work for consulting firm Avalere to build a device recall database. Critical information, like unique device identifiers that help hospitals keep track of implants in patients, was often missing. Patients and doctors alike often knew very little about the safety record of their devices.
Insurance 116
116 
Opinion: Another Ebola outbreak, another missed opportunity for preparedness
STAT
JANUARY 11, 2023
When I learned that an outbreak of Ebola was declared in Uganda last fall, I had a flashback to 2014 when I was working at Merck and an outbreak of Ebola disease caused by a different species of the virus emerged in full force in West Africa.
Vaccines 94
94 Vaccines 94
94 
Can you take Zyrtec while pregnant?
The Checkup by Singlecare
NOVEMBER 30, 2023
A 2014 review of studies summarizes this uncertainty, noting that some studies suggest it can help while others have been unable to confirm a link. Getting acupuncture. Dr. Swarup also notes that acupuncture has been studied for the treatment of allergies, though the evidence is inconclusive.
FDA 114
114 
Company profile: NeoImmuneTech
pharmaphorum
NOVEMBER 29, 2022
At NeoImmuneTech, a Biotech company founded in Maryland, US, in 2014, the answer to this question looks straightforward: “We believe in incremental progress”, says Dr Se Hwan Yang, president and chief executive officer of the company. Dr Se Hwan Yang, PhD, President and Chief Executive Officer, founded NeoImmuneTech in January 2014.
Immunization 105
105 
UK £62 billion behind in R&D global investment share, report reveals
European Pharmaceutical Review
NOVEMBER 2, 2022
The UK’s share of global research and development ( R&D ) investment has fallen by a fifth since 2014, according to recent data analysis by the Institute for Public Policy Research (IPPR). percent in 2014. percent GDP R&D investment. percent to 3.4 IPPR indicated that state investment drives private sector investment.
Genomic testing ‘should be offered to all cancer patients in Scotland’
pharmaphorum
NOVEMBER 27, 2022
. “If I had had that information at the beginning, I could have avoided the treatments I received that were never going to work,” added Stephen who was diagnosed with metastatic breast cancer in March 2014. “It would have saved me and the NHS a lot of money. It would have avoided false hope.”
104 
Does gabapentin help you sleep?
The Checkup by Singlecare
APRIL 14, 2024
A 2014 clinical trial of over 300 people with occasional insomnia found that gabapentin 250 milligrams (mg) and 500 mg lengthened the time people slept. Another 2014 study of over 200 people with occasional insomnia showed gabapentin 250 mg increased the total amount of time people slept. The maximum dosage is 1,800 mg per day.
Dosage 97
97 
Let's personalize your content